Clinical Trials
This section provides information about recently completed clinical trials. If you cannot find information about a particular clinical trial, you should note that results may not be available even after the trial ends. Some trials end before completion and results are never published.
Latest Clinical Trial Results
AUSTIN, Texas--(BUSINESS WIRE)--Jul 8, 2008 - Introgen
Therapeutics, Inc. (NASDAQ:INGN) announced today that it will host
a conference call with management and invited clinical experts on
Thursday, July 10, 2008 at 3:30 p.m. ET.
Introgen management...
Corifollitropin alfa meets primary endpoints in ENGAGE Trial
KENILWORTH, N.J., July 08, 2008 /PRNewswire-FirstCall/ --
Schering-Plough Corp., announced today that corifollitropin alfa,
its experimental, sustained follicle stimulant (SFS) met...
WellPoint's Health Outcomes Subsidiary HealthCore Finds Optimal
Outcomes Can Be Achieved Through Compliant Use of Orally
Administered Controllers
INDIANAPOLIS, July 08, 2008 /PRNewswire/ -- Compliance with
inhaled medications for asthma can improve...
GLP-1 Has Potential to Treat Type 2 Diabetes Using Emisphere's
Eligen(R) Technology
CEDAR KNOLLS, N.J., July 8, 2008 /PRNewswire-FirstCall/ --
Emisphere Technologies, Inc. today announced findings from a
clinical study assessing the oral delivery of...
ATLANTA--(BUSINESS WIRE)--July 8, 2008--Sciele Pharma, Inc.
(NASDAQ:SCRX) today announced that it has completed its phase III
safety trial utilizing a liquid formulation of glycopyrrolate to
treat chronic, moderate-to-severe drooling in pediatric...
- Focalin XR demonstrated better symptom control versus Concerta
from 30 minutes to six hours post-dose in primary and secondary
endpoints
EAST HANOVER, N.J., July 08, 2008 /PRNewswire/ -- A head-to-head
study, published in the June Journal of Child...
CHICAGO, July 7, 2008—A class of antidepressants known as
selective serotonin reuptake inhibitors (SSRIs) appear to be
associated with bleeding in the upper gastrointestinal tract,
according to a report in the July issue of Archives of...
HORSHOLM, Denmark--(BUSINESS WIRE)--Jul 8, 2008 - LifeCycle Pharma
A/S (OMX:LCP) today announced positive top-line results from a
completed Phase II clinical study of LCP-Tacro tablets in stable
liver transplant patients which are in line with...
-Patient adherence essential in
reducing risk of cardiovascular disease-
KIRKLAND, QC, July 7 /CNW/ - Despite
the proven benefits of blood pressure and cholesterol medications
for the prevention of cardiovascular events(1) and...
- Dimebon Significantly Improves Cognition and is Well Tolerated in
Huntington's Disease Patients -
SAN FRANCISCO, July 07, 2008 /PRNewswire-FirstCall/ --
Medivation, Inc. today announced top-line results of a Phase 2
study showing that its...
NEW YORK--(BUSINESS WIRE)--Jul 7, 2008 - Pfizer announced today
that new statin users who took Lipitor (atorvastatin calcium)
were significantly more likely to stay on their medication compared
to those who took simvastatin, according to an...
A ubiquitous housekeeping enzyme has been found to play a
major role in keeping the bone marrow environment healthy so it can
nurture hematopoietic stem cells
MEMPHIS, Tenn., July 7 /PRNewswire-USNewswire/ -- The lack of a
single protein usually...
Molecular Biometrics presents scientific evidence supporting
accuracy of its biospectroscopy-based metabolomics platform at
major international conference.
BARCELONA, Spain and CHESTER, N.J., July 07, 2008 /PRNewswire/
-- Molecular Biometrics, LLC,...
HONG KONG, July 07, 2008 /PRNewswire/ -- OrbusNeich today
announced that data presented recently at the 17th Annual Meeting
of the Japanese Society of Interventional Cardiology demonstrate
that the Genous Bio-engineered R stent has better outcomes...
ATLANTA, July 07, 2008 /PRNewswire-FirstCall/ -- GeoVax Labs,
Inc. , an Atlanta based, publicly traded biopharmaceutical company
specializing in the prevention and treatment of infectious
diseases, today provided an operational update on the...
LONDON, July 3, 2008--Post-operative kidney
cancer patients show no increased recurrence-free survival (RFS)
when given the new vitespen vaccine. However a possible improvement
in RFS in patients with early stage disease given this vaccine
needs...
LONDON, July 3, 2008--A range of new and
developing treatments for Crohn’s disease are targeting not
only on the autoimmune response associated with the condition, but
also aiming to reinforce the intestinal barrier. These treatments
and their...
LONDON, July 3, 2008--Female recipients of male
donor kidneys have a higher rate of graft failure than other
combinations of donor and recipient. Consideration of sex should be
integrated into future studies and decisions on organ...
LONDON, July 3, 2008--A new care
package—‘Depression Care for People with Cancer’
(DCPC)—can reduce levels of depression in cancer patients and
is cost-effective in improving cancer patients’ quality of
life when...
BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--July 7, 2008 - ALIGN
Pharmaceuticals, LLC, a wholly owned subsidiary of Cyclacel
Pharmaceuticals, Inc., (NASDAQ: CYCC, CYCCP) announced results of a
double-blinded, randomized, vehicle-controlled clinical...
More...Clinical Trial Results Archive
2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Dec
